← Back to All Filings

CME Group Chief Transformation Officer Receives Annual Restricted Stock Grant

Low SignificanceSeptember 17, 2026 at 6:04:05 PM EDT

CME GROUP INC.

$CME4CIK: 0001156375

Subscribe to track CME

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

# CME Group Inc. (CME) - Form 4 Filing
**Reporting Owner:** Ken Vroman (Chief Transformation Officer)
**Filing Date:** September 17, 2026
**Transaction Date:** September 15-16, 2026

### Summary of Transactions
- **Grant (Code A):** 2,592 shares of Class A Common Stock @ $275.09 ($713,033.28 total value)
- **Tax Withholdings (Code F):** Total of 1,211 shares surrendered across Sept 15 and 16 to satisfy tax withholding obligations upon vesting
- **Post-Transaction Holdings:** 20,232 shares (Direct)

*Significance:* Low (Routine equity award and associated tax withholding)

Comprehensive Analysis

Executive Summary

On September 17, 2026, CME Group Inc. ($CME) filed a Form 4 for Ken Vroman, the company's Chief Transformation Officer. The filing reports the grant of 2,592 shares of Class A Common Stock on September 15, 2026, alongside four separate dispositions representing shares withheld to cover tax liabilities associated with restricted stock vesting.

Transaction Breakdown

  1. Equity Award (Code A - September 15, 2026):

    • Shares Acquired: 2,592 shares of Common Stock Class A
    • Price: $275.09 per share (grant reference price)
    • Stated Value: $713,033.28
    • Terms: Awarded under the CME Group Omnibus Stock Plan, vesting in four equal annual installments subject to continued service.
  2. Tax Withholdings (Code F - September 15 & 16, 2026):

    • September 15, 2026: Surrendered 320 shares, 309 shares, and 274 shares at $275.09 each (903 shares total, ~$248,406.27).
    • September 16, 2026: Surrendered 308 shares at $272.46 each (~$83,917.68).
    • Total Withheld: 1,211 shares (~$332,323.95) to satisfy statutory tax obligations on previously granted restricted stock.

Ownership Position

Following these transactions, Ken Vroman directly holds 20,232 shares of CME Group Class A Common Stock, representing a net increase of 1,381 shares from his pre-transaction balance.

Market Impact & Significance

The trading significance of this filing is categorized as Low. These transactions reflect routine executive compensation grants and nondiscretionary share withholdings to satisfy tax obligations, rather than open-market purchases or sales.

Topics:#CME#Form4#InsiderTrading#ExecutiveCompensation#StockGrant

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.